These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1698924)

  • 1. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli.
    Mason PW; Zügel MU; Semproni AR; Fournier MJ; Mason TL
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2107-14. PubMed ID: 1698924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus.
    Hall RA; Kay BH; Burgess GW; Clancy P; Fanning ID
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2923-30. PubMed ID: 1703213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1.
    Falconar AK; Young PR
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():961-5. PubMed ID: 1849979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
    Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of yellow fever virus proteins E and NS1 expressed in Vero and Spodoptera frugiperda cells.
    Desprès P; Girard M; Bouloy M
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1331-42. PubMed ID: 1710649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
    León-Juárez M; García-Cordero J; Santos-Argumedo L; Romero-Ramírez H; García-Machorro J; Bustos-Arriaga J; Gutiérrez-Castañeda B; Sepúlveda NV; Mellado-Sánchez G; Cedillo-Barrón L
    APMIS; 2013 Sep; 121(9):848-58. PubMed ID: 23331315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice.
    Desprès P; Dietrich J; Girard M; Bouloy M
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2811-6. PubMed ID: 1834798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK
    Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.
    Falconar AK
    Clin Vaccine Immunol; 2008 Mar; 15(3):549-61. PubMed ID: 18160621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH
    Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.
    Srivastava AK; Putnak JR; Warren RL; Hoke CH
    Vaccine; 1995 Sep; 13(13):1251-8. PubMed ID: 8578812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates.
    Hermida L; Bernardo L; Martín J; Alvarez M; Prado I; López C; Sierra Bde L; Martínez R; Rodríguez R; Zulueta A; Pérez AB; Lazo L; Rosario D; Guillén G; Guzmán MG
    Vaccine; 2006 Apr; 24(16):3165-71. PubMed ID: 16490289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
    Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
    Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
    Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes.
    Fuchs W; Rziha HJ; Lukàcs N; Braunschweiger I; Visser N; Lütticken D; Schreurs CS; Thiel HJ; Mettenleiter TC
    J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.
    Mason PW; Dalrymple JM; Gentry MK; McCown JM; Hoke CH; Burke DS; Fournier MJ; Mason TL
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2037-49. PubMed ID: 2549181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.